Intermittent Vs Continuous Vlcd Therapy in Obesity Treatment
Year-long weight loss treatment for obese patients with type II diabetes: Does including an intermittent very-low-calorie diet improve outcome?☆
Abstract
purpose: To evaluate a year-long behavioral weight control program, used with and without an intermittent very-low-calorie diet (VLCD) in the treatment of type II diabetes mellitus.
patients and methods: Subjects (n = 93) were randomly assigned to 50-week treatment programs that used either a balanced low-calorie diet (LCD) of 1,000 to 1,200 kilocalories (kcal) per day throughout or included 2 12-week periods of a VLCD of 400 to 500 kcal per day alternating with the balanced LCD. Weight, glycemic control, blood pressure, and lipids were assessed at baseline, at the end of the year-long treatment, and at 2-year follow-up.
results: Subjects in the VLCD program lost significantly more weight than did LCD subjects at the end of the 50-week program (14.2 kg versus 10.5 kg; P = 0.057) and remained off diabetes medication longer (P <0.05). These benefits of the VLCD were due primarily to the first 12 weeks of the diet; the second diet maintained, but did not increase, these effects. Subjects in both groups experienced marked improvements in glycemic control and cardiovascular risk factors over the year-long program, but attendance declined in the latter weeks of treatment and weight was regained. There was also marked recidivism in both groups in the year following treatment.
conclusions: The intermittent VLCD improved weight loss and glycemic control, but these effects were quite modest and do not appear to justify the clinical use of an intermittent VLCD. Moreover, lengthening treatment to a full year did not prevent relapse. Thus, further research is needed to develop a successful approach to long-term weight control.
References (35)
- et al.
Factors affecting glycosylated hemoglobin values in children with insulin-dependent diabetes
J Pediatr.
(1981)
- et al.
Effects of caloric restriction and weight loss on glycemia control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus
Am J Med.
(1984)
-
Memorandum on federal government ability to oversee $33 billion diet business
(1990)
- et al.
A multicenter evaluation of a proprietary weight reduction program for the treatment of marked obesity
Arch Intern Med.
(1992)
- et al.
An eight-year experience with a very-low-calorie formula diet for control of major obesity
Int J Obesity
(1988)
- et al.
Long-term weight loss maintenance: assessment of a behavioral and supplemented fasting regimen
Am J Public Health
(1988)
- et al.
Supplemented fasting as a large scale outpatient program
JAMA
(1977)
- et al.
The long term effectiveness of combined therapy by behavior modification and very low calorie diet: 2 years follow-up
Int J Obesity
(1989)
- et al.
Controlled trial of very low calorie diet, behavior therapy, and their combination in the treatment of obesity
J Consult Clin Psychol.
(1986)
- et al.
Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects
Arch Intern Med.
(1991)
Long-term effects of dieting on resting metabolic rate in obese outpatients
JAMA
(1990)
One-year behavioral treatment of obesity: comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy
J Consult Clin Psychol.
(1994)
Very low calorie diets: their efficacy, safety, and future
Ann Intern Med.
(1983)
Very low-calorie diets
JAMA
(1993)
Behavioral treatment of severe obesity
Am J Clin Nutr.
(1992)
Treatment of obesity by moderate and severe caloric restriction: results of clinical research trials
Ann Intern Med.
(1993)
Evidence for success of behavior modification in weight loss and control
Ann Intern Med.
(1993)
Cited by (180)
-
Understanding the mechanisms of reversal of type 2 diabetes
2019, The Lancet Diabetes and Endocrinology
Retinal imaging within 4–6 months should be required for individuals in the post-diabetes state with more than minimal retinopathy. Calorie restriction to achieve substantial weight loss and remission of type 2 diabetes has previously been observed,30,86 raising the question of how best to maintain the initial advantage provided by a low-calorie liquid diet. Recent national dietary guidelines have emphasised the need to provide individualised advice, rather than only one dietary prescription for everyone, and high quality studies in primary care are needed to assess the dietary advice and the nature of the behavioural support provided to maintain remission of type 2 diabetes.
-
Protein sparing therapies in acute illness and obesity: a review of George Blackburn's contributions to nutrition science
2018, Metabolism: Clinical and Experimental
The VLCD treatment was separated into two 12-week periods. Subjects assigned to the VCLD group were significantly more likely to remain off diabetes medications after 2-years of follow up [105]. Wing et al. randomized 93 patients with type 2 diabetes to either 1000 kcal/day balanced diet or 400 kcal/day VLCD consisting of either lean meat, fish, or fowl or Optifast formula for 12 weeks and examined changes in insulin sensitivity by frequently sampled intravenous glucose tolerance testing.
Recommended articles (6)
Copyright © 1994 Published by Excerpta Medica Inc.
Source: https://www.sciencedirect.com/science/article/abs/pii/0002934394903026
Post a Comment for "Intermittent Vs Continuous Vlcd Therapy in Obesity Treatment"